{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:49:52Z","timestamp":1792705792886,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DE022350"],"award-info":[{"award-number":["DE022350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI175024"],"award-info":[{"award-number":["AI175024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI134685"],"award-info":[{"award-number":["AI134685"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR072000"],"award-info":[{"award-number":["AR072000"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bmcl.2025.130164","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T12:02:09Z","timestamp":1741003329000},"page":"130164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Phenyl urea based adjuvants for \u03b2-lactam antibiotics against methicillin resistant Staphylococcus aureus"],"prefix":"10.1016","volume":"121","author":[{"given":"Hailey S.","family":"Butman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A.","family":"Stefaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay S.","family":"Gondil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaeel","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Crow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansley M.","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta J.","family":"Melander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Dunman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Melander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130164_bb0005","series-title":"Antibiotic resistance threats in the United States, 2013","author":"CDC","year":"2013"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130164_bb0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130164_bb0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/acsinfecdis.7b00071","article-title":"The challenge of overcoming antibiotic resistance: an adjuvant approach?","volume":"3","author":"Melander","year":"2017","journal-title":"ACS Infect Dis"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130164_bb0020","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","article-title":"Antibiotic adjuvants: rescuing antibiotics from resistance","volume":"24","author":"Wright","year":"2016","journal-title":"Trends Microbiol"},{"issue":"18","key":"10.1016\/j.bmcl.2025.130164_bb0025","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.bmcl.2017.08.027","article-title":"Antibiotic adjuvants - a strategy to unlock bacterial resistance to antibiotics","volume":"27","author":"Gonz\u00e1lez-Bello","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"issue":"suppl 2","key":"10.1016\/j.bmcl.2025.130164_bb0030","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.ijantimicag.2007.07.015","article-title":"Introduction: historical perspective and development of amoxicillin\/clavulanate","volume":"30","author":"Geddes","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmcl.2025.130164_bb0035","doi-asserted-by":"crossref","unstructured":"Bush K, Bradford PA. \u03b2-Lactams and \u03b2-Lactamase Inhibitors: an overview. Cold Spring Harb Perspect Med. 2016;Vol. 6(8).","DOI":"10.1101\/cshperspect.a025247"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130164_bb0040","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1021\/jo400236f","article-title":"Overcoming resistance to beta-lactam antibiotics","volume":"78","author":"Worthington","year":"2013","journal-title":"J Organomet Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130164_bb0045","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1039\/D1MD00200G","article-title":"\u03b2-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates","volume":"12","author":"Mora-Ochomogo","year":"2021","journal-title":"RSC Med Chem"},{"issue":"7943","key":"10.1016\/j.bmcl.2025.130164_bb0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41586-022-05583-3","article-title":"Structural basis of broad-spectrum \u03b2-lactam resistance in Staphylococcus aureus","volume":"613","author":"Alexander","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130164_bb0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/cr030102i","article-title":"Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity","volume":"105","author":"Fisher","year":"2005","journal-title":"Chem Rev"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130164_bb0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/femsre\/fux007","article-title":"Antibiotic resistance in Staphylococcus aureus. Current status and future prospects","volume":"41","author":"Foster","year":"2017","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130164_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/JB.00822-09","article-title":"Molecular basis for the role of Staphylococcus aureus penicillin binding protein 4 in antimicrobial resistance","volume":"192","author":"Navratna","year":"2010","journal-title":"J Bacteriol"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130164_bb0070","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1128\/AAC.00049-08","article-title":"Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains","volume":"52","author":"Memmi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 2","key":"10.1016\/j.bmcl.2025.130164_bb0075","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1086\/513854","article-title":"Penicillin-binding protein-mediated resistance in pneumococci and staphylococci","volume":"179","author":"Chambers","year":"1999","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130164_bb0080","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1128\/JB.187.5.1815-1824.2005","article-title":"Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A","volume":"187","author":"\u0141eski","year":"2005","journal-title":"J Bacteriol"},{"issue":"42","key":"10.1016\/j.bmcl.2025.130164_bb0085","doi-asserted-by":"crossref","first-page":"16808","DOI":"10.1073\/pnas.1300118110","article-title":"How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function","volume":"110","author":"Otero","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130164_bb0090","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/iub.1289","article-title":"Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus","volume":"66","author":"Fishovitz","year":"2014","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130164_bb0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1432-1033.1981.tb05620.x","article-title":"A role in vivo for penicillin-binding protein-4 of Staphylococcus aureus","volume":"119","author":"Wyke","year":"1981","journal-title":"Eur J Biochem"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130164_bb0100","article-title":"Identification of identification of Staphylococcus aureus penicillin binding protein 4 (PBP4) inhibitors","volume":"11","author":"Young","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"51","key":"10.1016\/j.bmcl.2025.130164_bb0105","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1074\/jbc.RA118.004952","article-title":"Structural and kinetic analyses of penicillin-binding protein 4 (PBP4)-mediated antibiotic resistance in","volume":"293","author":"Alexander","year":"2018","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130164_bb0110","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02727-16","article-title":"High-level resistance of Staphylococcus aureus to \u03b2-lactam antibiotics mediated by penicillin-binding protein 4 (PBP4)","volume":"61","author":"Hamilton","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130164_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008988","article-title":"Identification of penicillin binding protein 4 (PBP4) as a critical factor for Staphylococcus aureus bone invasion during osteomyelitis in mice","volume":"16","author":"Masters","year":"2020","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130164_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14569","article-title":"Development of phenyl-urea-based small molecules that target penicillin-binding protein 4","volume":"103","author":"Gondil","year":"2024","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmcl.2025.130164_bb0125","series-title":"Performance Standards for Antimicrobial Suceptibility Testing; Nineteenth Informational Supplement","author":"CLSI","year":"2009"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130164_bb0130","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1542\/pir.29.8.264","article-title":"Cephalosporins: a review","volume":"29","author":"Harrison","year":"2008","journal-title":"Pediatr Rev"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:29:51Z","timestamp":1777642191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25000733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":26,"alternative-id":["S0960894X25000733"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130164","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenyl urea based adjuvants for \u03b2-lactam antibiotics against methicillin resistant Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130164"}}